| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 228,283 | 232,511 | 154,891 | 369,234 | | Cost of Revenue | 124,109 | 148,158 | 92,731 | 105,074 | | | Gross Profit | 104,174 | 84,353 | 62,160 | 264,160 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 68,883 | 77,329 | 53,093 | 49,858 | | Non Recurring | 4,541 | 561,553 | 18,812 | 13,651 | | Others | 11,815 | 14,386 | 14,293 | 224,027 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 18,935 | (568,915) | (24,038) | (23,376) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 309 | 15,639 | 475 | 594 | | Earnings Before Interest And Taxes | 19,244 | (553,276) | (23,563) | (22,782) | | Interest Expense | 38,999 | 38,865 | 39,258 | 35,249 | | Income Before Tax | (19,755) | (592,141) | (62,821) | (58,031) | | Income Tax Expense |
-
| (8,324) |
-
| (3,994) | | Minority Interest | 4,642 | 153,391 |
-
| 13,387 | | | | Net Income From Continuing Ops | (173,146) | (430,426) | (62,821) | (40,650) | | | Non-recurring Events | | Discontinued Operations |
-
| 2,742 | (2,742) | (3,941) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,113) | (427,684) | (65,563) | (44,591) | | Preferred Stock And Other Adjustments |
-
| (15,408) | 15,408 |
-
| | | Net Income Applicable To Common Shares | ($15,113) | ($443,092) | ($50,155) | ($44,591) |
|
1.00% Nasdaq 0.00%
Income Statement
